Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
| Active as of 2022-01-10 |
<Citation xmlns="http://hl7.org/fhir">
<id value="7638"/>
<meta>
<versionId value="32"/>
<lastUpdated value="2023-12-02T12:42:05.125Z"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Citation</b><a name="7638"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Citation "7638" Version "32" Updated "2023-12-02 12:42:05+0000" </p></div><p><b>StructureDefinition Work Group</b>: cds</p><p><b>url</b>: <code>https://fevir.net/resources/Citation/7638</code></p><p><b>identifier</b>: FEvIR Object Identifier: 7638</p><p><b>version</b>: 1.0.0-ballot</p><p><b>title</b>: Citation for FEvIR Evidence 7637: Critically appraised summary of primary outcome of multi-platform RCT of anticoagulation for non-critically ill COVID-19</p><p><b>status</b>: active</p><p><b>date</b>: 2022-01-10 13:30:43+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href="http://www.hl7.org/Special/committees/dss">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: A Evidence Resource to demonstrate complex evidence reporting</p><h3>UseContexts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style="display: none">*</td><td>Program (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code program = 'Program', stated as 'Program')</td><td>EBMonFHIR/COKA Demonstration <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></td></tr><tr><td style="display: none">*</td><td>FEvIR Platform Use (Details: http://hl7.org/fhir/citation-classification-type code fevir-platform-use = 'FEvIR Platform Use', stated as 'FEvIR Platform Use')</td><td>Evidence <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-citation-artifact-classifier.html">Citation Artifact Classifier</a>#fhir-resource "FHIR Resource")</span></td></tr></table><p><b>jurisdiction</b>: World <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (m49.htm#001)</span></p><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>author</b>: Brian S. Alper: </p><h3>Summaries</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Style</b></td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td>Computable Publishing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-citation-summary-style.html">Citation Summary Style</a>#comppub)</span></td><td>Critically appraised summary of primary outcome of multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19 [FHIR Resource]. Contributors: Brian S Alper, Harold Lehmann, Ahmad Sofi-Mahmudi, Joanne Dehnbostel, Ilkka Kunnamo [Authors]; Janice Tufte, Vignesh Subbian, Bhagvan Kommadi, Alfonso Iorio, Muhammad Afzal, Kenneth J Wilkins, Surbhi Shah, Amy Price [Reviewers]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 7637. Published August 05, 2021. Created August 05, 2021. Revised August 25, 2021. Available at: https://fevir.net/resources/Evidence/7637. Computable resource at: https://fevir.net/resources/Evidence/7637.</td></tr></table><h3>Classifications</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Classifier</b></td></tr><tr><td style="display: none">*</td><td>FEvIR Platform Use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-citation-classification-type.html">Citation Classification Type</a>#fevir-platform-use)</span></td><td>Project Specific <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-citation-artifact-classifier.html">Citation Artifact Classifier</a>#project-specific)</span></td></tr></table><blockquote><p><b>citedArtifact</b></p><p><b>identifier</b>: FEvIR Object Identifier: 7637</p><p><b>relatedIdentifier</b>: id: 10.1056/NEJMoa2105911</p><h3>StatusDates</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Activity</b></td><td><b>Actual</b></td><td><b>Period</b></td></tr><tr><td style="display: none">*</td><td>Created <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-cited-artifact-status-type.html">Cited Artifact Status Type</a>#created)</span></td><td>true</td><td>2021-08-05 --> (ongoing)</td></tr></table><blockquote><p><b>title</b></p><p><b>type</b>: Primary title <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-title-type.html">Title Type</a>#primary)</span>, Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-title-type.html">Title Type</a>#human-use)</span></p><p><b>language</b>: English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></p><p><b>text</b>: Critically appraised summary of primary outcome of multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19</p></blockquote><blockquote><p><b>title</b></p><p><b>type</b>: Different text in an earlier version <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-title-type.html">Title Type</a>#earlier-title)</span></p><p><b>language</b>: English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></p><p><b>text</b>: Critically appraised summary of primary outcome of multi-platform RCT of anticoagulation for non-critically ill COVID-19</p></blockquote><blockquote><p><b>abstract</b></p><p><b>type</b>: Description <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#description)</span></p><p><b>language</b>: English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></p><p><b>text</b>: Patients who were hospitalized for COVID-19 and who were not critically ill were randomized in a response-adaptive manner to therapeutic-dose anticoagulation with heparin vs. usual-care pharmacologic thromboprophylaxis. The outcome reported here is the effect on organ support-free days (i.e. days without oxygen delivered by high-flow nasal cannula, noninvasive or invasive mechanical ventilation, or the use of vasopressors or inotropes). The statistical result was a median adjusted odds ratio 1.27 (95% credible interval 1.03 to 1.58), based on 1,740 events among 2,219 participants with known outcome out of 2,244 enrolled participants. The probability of superiority of therapeutic-dose anticoagulation with heparin was 98.6%. The risk of bias in this effect estimate is of extremely serious concern based on a serious concern for confounding covariate bias (confounding difference in calendar time), a very serious concern for performance bias (inadequate blinding of intervention deliverers who may determine the outcome based in part on exposure status), and very serious concern for analysis bias (bias related to selection of the analysis, and early trial termination).</p></blockquote><blockquote><p><b>abstract</b></p><p><b>type</b>: Assertion <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#assertion)</span></p><p><b>language</b>: English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></p><p><b>text</b>: It is uncertain whether therapeutic-dose anticoagulation with heparin affects the rate of organ support-free days in hospitalized patients with COVID-19 who are not critically ill.</p></blockquote><blockquote><p><b>relatesTo</b></p><p><b>type</b>: cites</p><p><b>classifier</b>: Journal Article <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-citation-artifact-classifier.html">Citation Artifact Classifier</a>#D016428)</span></p><p><b>citation</b>: Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 [Journal Article]. Contributors: The ATTACC, ACTIV-4a, and REMAP-CAP Investigators. In: The New England Journal of Medicine, DOI 10.1056/NEJMoa2105911. Published August 04, 2021. Available at: https://doi.org/10.1056/NEJMoa2105911.</p><h3>Documents</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Url</b></td></tr><tr><td style="display: none">*</td><td><a href="Citation-7636.html">Anticoagulation for COVID-19 Combined RCTs in NEJM</a></td></tr></table><p><b>resourceReference</b>: <span>FEvIR Object Identifier: 7636</span></p></blockquote><blockquote><p><b>publicationForm</b></p><h3>PublishedIns</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Title</b></td><td><b>Publisher</b></td><td><b>PublisherLocation</b></td></tr><tr><td style="display: none">*</td><td>Database <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-published-in-type.html">Published In Type</a>#D019991)</span></td><td>Fast Evidence Interoperability Resources (FEvIR) Platform</td><td><span>: Computable Publishing LLC</span></td><td>Ipswich, MA, USA</td></tr></table><p><b>articleDate</b>: 2021-08-05</p><p><b>lastRevisionDate</b>: 2021-08-25</p><p><b>language</b>: English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></p><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p></blockquote><h3>WebLocations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Classifier</b></td><td><b>Url</b></td></tr><tr><td style="display: none">*</td><td>Computable resource <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-url-classifier.html">Artifact Url Classifier</a>#computable-resource)</span>, JSON <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-url-classifier.html">Artifact Url Classifier</a>#json)</span></td><td><a href="Evidence-7637.html">Critically appraised summary of primary outcome of multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19</a></td></tr></table><blockquote><p><b>classification</b></p><p><b>type</b>: Knowledge Artifact Type <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-cited-artifact-classification-type.html">Cited Artifact Classification Type</a>#knowledge-artifact-type)</span></p><p><b>classifier</b>: FHIR Resource <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-citation-artifact-classifier.html">Citation Artifact Classifier</a>#fhir-resource)</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: fhir-resource <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-citation-artifact-classifier.html">Citation Artifact Classifier</a>#fhir-resource "FHIR Resource")</span></p><p><b>classifier</b>: Evidence <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-fhir-types.html">All FHIR Types</a>#Evidence)</span></p></blockquote><blockquote><p><b>contributorship</b></p><p><b>complete</b>: true</p><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor0"> </a></p><blockquote><p/><p><a name="contributor0"> </a></p><p><b>identifier</b>: id: 0000-0003-4300-4928</p><p><b>name</b>: Brian S Alper </p><p><b>telecom</b>: <a href="mailto:balper@computablepublishing.com">balper@computablepublishing.com</a></p></blockquote><p><b>forenameInitials</b>: BS</p><p><b>affiliation</b>: </p><ul><li><span>: Computable Publishing LLC</span></li><li><span>: Scientific Knowledge Accelerator Foundation</span></li><li><span>: COVID-19 Knowledge Accelerator</span></li></ul><p><b>contributionType</b>: Conceptualization <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#conceptualization)</span>, Data curation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#data-curation)</span>, Investigation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#investigation)</span>, Methodology <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#methodology)</span>, Software <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#software)</span>, Writing - original draft <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-original-draft)</span></p><p><b>role</b>: Author/Creator <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#author)</span></p><h3>ContributionInstances</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Time</b></td></tr><tr><td style="display: none">*</td><td>Risk of bias assessment <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-text "Defined in text")</span></td><td>2021-08-05</td></tr></table><p><b>correspondingContact</b>: true</p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor1"> </a></p><blockquote><p/><p><a name="contributor1"> </a></p><p><b>identifier</b>: id: 0000-0002-4346-3238</p><p><b>name</b>: Janice Tufte </p><p><b>telecom</b>: <a href="mailto:hassanahseattle@gmail.com">hassanahseattle@gmail.com</a></p></blockquote><p><b>affiliation</b>: <span>: Hassanah Consulting</span></p><p><b>contributionType</b>: Writing - review & editing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-review-editing)</span>, Formal analysis <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#formal-analysis)</span>, Investigation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#investigation)</span>, Validation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#validation)</span></p><p><b>role</b>: Reviewer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#reviewer)</span></p><blockquote><p><b>contributionInstance</b></p><p><b>type</b>: Reviewed <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-instance-type.html">Artifact Contribution Instance Type</a>#reviewed)</span></p><p><b>time</b>: 2021-08-05</p></blockquote><blockquote><p><b>contributionInstance</b></p><p><b>type</b>: Reviewed <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-instance-type.html">Artifact Contribution Instance Type</a>#reviewed)</span></p><p><b>time</b>: 2021-08-06</p></blockquote></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor2"> </a></p><blockquote><p/><p><a name="contributor2"> </a></p><p><b>name</b>: Harold Lehmann </p><p><b>telecom</b>: <a href="mailto:lehmann@jhmi.edu">lehmann@jhmi.edu</a></p></blockquote><p><b>affiliation</b>: <span>: Johns Hopkins University</span></p><p><b>contributionType</b>: Investigation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#investigation)</span>, Methodology <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#methodology)</span>, Writing - original draft <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-original-draft)</span></p><p><b>role</b>: Author/Creator <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#author)</span></p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor3"> </a></p><blockquote><p/><p><a name="contributor3"> </a></p><p><b>name</b>: Ahmad Sofi-Mahmudi </p><p><b>telecom</b>: <a href="mailto:a.sofimahmudi@gmail.com">a.sofimahmudi@gmail.com</a></p></blockquote><p><b>affiliation</b>: <span>: Cochrane Iran Associate Centre</span></p><p><b>contributionType</b>: Investigation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#investigation)</span>, Methodology <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#methodology)</span>, Validation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#validation)</span>, Writing - review & editing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-review-editing)</span></p><p><b>role</b>: Author/Creator <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#author)</span></p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor4"> </a></p><blockquote><p/><p><a name="contributor4"> </a></p><p><b>name</b>: Joanne Dehnbostel </p><p><b>telecom</b>: <a href="mailto:jdehnbostel@computablepublishing.com">jdehnbostel@computablepublishing.com</a></p></blockquote><p><b>affiliation</b>: <span>: Computable Publishing LLC</span></p><p><b>contributionType</b>: Project administration <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#project-administration)</span>, Investigation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#investigation)</span>, Writing - review & editing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-review-editing)</span></p><p><b>role</b>: Author/Creator <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#author)</span></p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor5"> </a></p><blockquote><p/><p><a name="contributor5"> </a></p><p><b>name</b>: Vignesh Subbian </p><p><b>telecom</b>: <a href="mailto:vsubbian@arizona.edu">vsubbian@arizona.edu</a></p></blockquote><p><b>affiliation</b>: <span>: University of Arizona</span></p><p><b>contributionType</b>: Formal analysis <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#formal-analysis)</span>, Investigation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#investigation)</span>, Writing - review & editing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-review-editing)</span></p><p><b>role</b>: Reviewer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#reviewer)</span></p><h3>ContributionInstances</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Time</b></td></tr><tr><td style="display: none">*</td><td>Reviewed <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-instance-type.html">Artifact Contribution Instance Type</a>#reviewed)</span></td><td>2021-08-07</td></tr></table></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor6"> </a></p><blockquote><p/><p><a name="contributor6"> </a></p><p><b>identifier</b>: id: 0000-0002-4817-6991</p><p><b>name</b>: Ilkka Kunnamo </p><p><b>telecom</b>: <a href="mailto:ilkka.kunnamo@duodecim.fi">ilkka.kunnamo@duodecim.fi</a></p></blockquote><p><b>affiliation</b>: </p><ul><li><span>: Duodecim Medical Publications Ltd., Finland</span></li><li><span>: Scientific Knowledge Accelerator Foundation</span></li></ul><p><b>contributionType</b>: Writing - review & editing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-review-editing)</span></p><p><b>role</b>: Author/Creator <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#author)</span></p><h3>ContributionInstances</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Time</b></td></tr><tr><td style="display: none">*</td><td>Reviewed <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-instance-type.html">Artifact Contribution Instance Type</a>#reviewed)</span></td><td>2021-08-09</td></tr></table></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor7"> </a></p><blockquote><p/><p><a name="contributor7"> </a></p><p><b>name</b>: Bhagvan Kommadi </p><p><b>telecom</b>: <a href="mailto:bhagvanarch@gmail.com">bhagvanarch@gmail.com</a></p></blockquote><p><b>affiliation</b>: <span>: Value Momentum</span></p><p><b>contributionType</b>: Methodology <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#methodology)</span>, Validation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#validation)</span></p><p><b>role</b>: Reviewer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#reviewer)</span></p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor8"> </a></p><blockquote><p/><p><a name="contributor8"> </a></p><p><b>name</b>: Alfonso Iorio </p></blockquote><p><b>affiliation</b>: <span>: McMaster University</span></p><p><b>contributionType</b>: Formal analysis <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#formal-analysis)</span>, Writing - review & editing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-review-editing)</span></p><p><b>role</b>: Reviewer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#reviewer)</span></p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor9"> </a></p><blockquote><p/><p><a name="contributor9"> </a></p><p><b>name</b>: Muhammad Afzal </p><p><b>telecom</b>: <a href="mailto:afzalse@gmail.com">afzalse@gmail.com</a></p></blockquote><p><b>affiliation</b>: <span>: Sejong University, Seoul, South Korea</span></p><p><b>contributionType</b>: Formal analysis <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#formal-analysis)</span>, Writing - review & editing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-review-editing)</span></p><p><b>role</b>: Reviewer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#reviewer)</span></p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor10"> </a></p><blockquote><p/><p><a name="contributor10"> </a></p><p><b>name</b>: Kenneth J Wilkins </p></blockquote><p><b>affiliation</b>: <span>: National Institute of Diabetes & Digestive & Kidney Diseases</span></p><p><b>contributionType</b>: Formal analysis <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#formal-analysis)</span>, Writing - review & editing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-review-editing)</span></p><p><b>role</b>: Reviewer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#reviewer)</span></p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor11"> </a></p><blockquote><p/><p><a name="contributor11"> </a></p><p><b>name</b>: Surbhi Shah </p></blockquote><p><b>affiliation</b>: <span>: Mayo Clinic Arizona</span></p><p><b>contributionType</b>: Writing - review & editing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-review-editing)</span>, Clinical commentary <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-text "Defined in text")</span></p><p><b>role</b>: Reviewer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#reviewer)</span></p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor12"> </a></p><blockquote><p/><p><a name="contributor12"> </a></p><p><b>name</b>: Amy Price </p></blockquote><p><b>contributionType</b>: Writing - review & editing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#writing-review-editing)</span></p><p><b>role</b>: Reviewer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#reviewer)</span></p></blockquote></blockquote></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor0</b><a name="contributor0"> </a></p><p><b>identifier</b>: id: 0000-0003-4300-4928</p><p><b>name</b>: Brian S Alper </p><p><b>telecom</b>: <a href="mailto:balper@computablepublishing.com">balper@computablepublishing.com</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor1</b><a name="contributor1"> </a></p><p><b>identifier</b>: id: 0000-0002-4346-3238</p><p><b>name</b>: Janice Tufte </p><p><b>telecom</b>: <a href="mailto:hassanahseattle@gmail.com">hassanahseattle@gmail.com</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor2</b><a name="contributor2"> </a></p><p><b>name</b>: Harold Lehmann </p><p><b>telecom</b>: <a href="mailto:lehmann@jhmi.edu">lehmann@jhmi.edu</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor3</b><a name="contributor3"> </a></p><p><b>name</b>: Ahmad Sofi-Mahmudi </p><p><b>telecom</b>: <a href="mailto:a.sofimahmudi@gmail.com">a.sofimahmudi@gmail.com</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor4</b><a name="contributor4"> </a></p><p><b>name</b>: Joanne Dehnbostel </p><p><b>telecom</b>: <a href="mailto:jdehnbostel@computablepublishing.com">jdehnbostel@computablepublishing.com</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor5</b><a name="contributor5"> </a></p><p><b>name</b>: Vignesh Subbian </p><p><b>telecom</b>: <a href="mailto:vsubbian@arizona.edu">vsubbian@arizona.edu</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor6</b><a name="contributor6"> </a></p><p><b>identifier</b>: id: 0000-0002-4817-6991</p><p><b>name</b>: Ilkka Kunnamo </p><p><b>telecom</b>: <a href="mailto:ilkka.kunnamo@duodecim.fi">ilkka.kunnamo@duodecim.fi</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor7</b><a name="contributor7"> </a></p><p><b>name</b>: Bhagvan Kommadi </p><p><b>telecom</b>: <a href="mailto:bhagvanarch@gmail.com">bhagvanarch@gmail.com</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor8</b><a name="contributor8"> </a></p><p><b>name</b>: Alfonso Iorio </p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor9</b><a name="contributor9"> </a></p><p><b>name</b>: Muhammad Afzal </p><p><b>telecom</b>: <a href="mailto:afzalse@gmail.com">afzalse@gmail.com</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor10</b><a name="contributor10"> </a></p><p><b>name</b>: Kenneth J Wilkins </p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor11</b><a name="contributor11"> </a></p><p><b>name</b>: Surbhi Shah </p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor12</b><a name="contributor12"> </a></p><p><b>name</b>: Amy Price </p></blockquote></div>
</text>
<contained>
<Practitioner>
<id value="contributor0"/>
<identifier>
<system value="https://orcid.org/"/>
<value value="0000-0003-4300-4928"/>
</identifier>
<name>
<family value="Alper"/>
<given value="Brian S"/>
</name>
<telecom>
<system value="email"/>
<value value="balper@computablepublishing.com"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor1"/>
<identifier>
<system value="https://orcid.org/"/>
<value value="0000-0002-4346-3238"/>
</identifier>
<name>
<family value="Tufte"/>
<given value="Janice"/>
</name>
<telecom>
<system value="email"/>
<value value="hassanahseattle@gmail.com"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor2"/>
<name>
<family value="Lehmann"/>
<given value="Harold"/>
</name>
<telecom>
<system value="email"/>
<value value="lehmann@jhmi.edu"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor3"/>
<name>
<family value="Sofi-Mahmudi"/>
<given value="Ahmad"/>
</name>
<telecom>
<system value="email"/>
<value value="a.sofimahmudi@gmail.com"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor4"/>
<name>
<family value="Dehnbostel"/>
<given value="Joanne"/>
</name>
<telecom>
<system value="email"/>
<value value="jdehnbostel@computablepublishing.com"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor5"/>
<name>
<family value="Subbian"/>
<given value="Vignesh"/>
</name>
<telecom>
<system value="email"/>
<value value="vsubbian@arizona.edu"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor6"/>
<identifier>
<system value="https://orcid.org/"/>
<value value="0000-0002-4817-6991"/>
</identifier>
<name>
<family value="Kunnamo"/>
<given value="Ilkka"/>
</name>
<telecom>
<system value="email"/>
<value value="ilkka.kunnamo@duodecim.fi"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor7"/>
<name>
<family value="Kommadi"/>
<given value="Bhagvan"/>
</name>
<telecom>
<system value="email"/>
<value value="bhagvanarch@gmail.com"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor8"/>
<name>
<family value="Iorio"/>
<given value="Alfonso"/>
</name>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor9"/>
<name>
<family value="Afzal"/>
<given value="Muhammad"/>
</name>
<telecom>
<system value="email"/>
<value value="afzalse@gmail.com"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor10"/>
<name>
<family value="Wilkins"/>
<given value="Kenneth J"/>
</name>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor11"/>
<name>
<family value="Shah"/>
<given value="Surbhi"/>
</name>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor12"/>
<name>
<family value="Price"/>
<given value="Amy"/>
</name>
</Practitioner>
</contained>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="cds"/>
</extension>
<url value="https://fevir.net/resources/Citation/7638"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="7638"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<version value="1.0.0-ballot"/>
<title
value="Citation for FEvIR Evidence 7637: Critically appraised summary of primary outcome of multi-platform RCT of anticoagulation for non-critically ill COVID-19"/>
<status value="active"/>
<date value="2022-01-10T13:30:43.053Z"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<name value="HL7 International / Clinical Decision Support"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description
value="A Evidence Resource to demonstrate complex evidence reporting"/>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="program"/>
<display value="Program"/>
</code>
<valueCodeableConcept>
<text value="EBMonFHIR/COKA Demonstration"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system value="http://hl7.org/fhir/citation-classification-type"/>
<code value="fevir-platform-use"/>
<display value="FEvIR Platform Use"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://hl7.org/fhir/citation-artifact-classifier"/>
<code value="fhir-resource"/>
<display value="FHIR Resource"/>
</coding>
<text value="Evidence"/>
</valueCodeableConcept>
</useContext>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<author>
<name value="Brian S. Alper"/>
</author>
<summary>
<style>
<coding>
<system value="http://hl7.org/fhir/citation-summary-style"/>
<code value="comppub"/>
<display value="Computable Publishing"/>
</coding>
</style>
<text
value="Critically appraised summary of primary outcome of multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19 [FHIR Resource]. Contributors: Brian S Alper, Harold Lehmann, Ahmad Sofi-Mahmudi, Joanne Dehnbostel, Ilkka Kunnamo [Authors]; Janice Tufte, Vignesh Subbian, Bhagvan Kommadi, Alfonso Iorio, Muhammad Afzal, Kenneth J Wilkins, Surbhi Shah, Amy Price [Reviewers]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 7637. Published August 05, 2021. Created August 05, 2021. Revised August 25, 2021. Available at: https://fevir.net/resources/Evidence/7637. Computable resource at: https://fevir.net/resources/Evidence/7637."/>
</summary>
<classification>
<type>
<coding>
<system value="http://hl7.org/fhir/citation-classification-type"/>
<code value="fevir-platform-use"/>
<display value="FEvIR Platform Use"/>
</coding>
</type>
<classifier>
<coding>
<system value="http://hl7.org/fhir/citation-artifact-classifier"/>
<code value="project-specific"/>
<display value="Project Specific"/>
</coding>
</classifier>
</classification>
<citedArtifact>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="7637"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<relatedIdentifier>
<system value="https://doi.org"/>
<value value="10.1056/NEJMoa2105911"/>
</relatedIdentifier>
<statusDate>
<activity>
<coding>
<system value="http://hl7.org/fhir/cited-artifact-status-type"/>
<code value="created"/>
<display value="Created"/>
</coding>
</activity>
<actual value="true"/>
<period>
<start value="2021-08-05"/>
</period>
</statusDate>
<title>
<type>
<coding>
<system value="http://hl7.org/fhir/title-type"/>
<code value="primary"/>
<display value="Primary title"/>
</coding>
</type>
<type>
<coding>
<system value="http://hl7.org/fhir/title-type"/>
<code value="human-use"/>
<display value="Human use"/>
</coding>
</type>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<text
value="Critically appraised summary of primary outcome of multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19"/>
</title>
<title>
<type>
<coding>
<system value="http://hl7.org/fhir/title-type"/>
<code value="earlier-title"/>
<display value="Different text in an earlier version"/>
</coding>
</type>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<text
value="Critically appraised summary of primary outcome of multi-platform RCT of anticoagulation for non-critically ill COVID-19"/>
</title>
<abstract>
<type>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="description"/>
<display value="Description"/>
</coding>
<text value="Description"/>
</type>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<text
value="Patients who were hospitalized for COVID-19 and who were not critically ill were randomized in a response-adaptive manner to therapeutic-dose anticoagulation with heparin vs. usual-care pharmacologic thromboprophylaxis. The outcome reported here is the effect on organ support-free days (i.e. days without oxygen delivered by high-flow nasal cannula, noninvasive or invasive mechanical ventilation, or the use of vasopressors or inotropes). The statistical result was a median adjusted odds ratio 1.27 (95% credible interval 1.03 to 1.58), based on 1,740 events among 2,219 participants with known outcome out of 2,244 enrolled participants. The probability of superiority of therapeutic-dose anticoagulation with heparin was 98.6%. The risk of bias in this effect estimate is of extremely serious concern based on a serious concern for confounding covariate bias (confounding difference in calendar time), a very serious concern for performance bias (inadequate blinding of intervention deliverers who may determine the outcome based in part on exposure status), and very serious concern for analysis bias (bias related to selection of the analysis, and early trial termination)."/>
</abstract>
<abstract>
<type>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="assertion"/>
<display value="Assertion"/>
</coding>
<text value="Assertion"/>
</type>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<text
value="It is uncertain whether therapeutic-dose anticoagulation with heparin affects the rate of organ support-free days in hospitalized patients with COVID-19 who are not critically ill."/>
</abstract>
<relatesTo>
<type value="cites"/>
<classifier>
<coding>
<system value="http://hl7.org/fhir/citation-artifact-classifier"/>
<code value="D016428"/>
<display value="Journal Article"/>
</coding>
</classifier>
<citation
value="Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 [Journal Article]. Contributors: The ATTACC, ACTIV-4a, and REMAP-CAP Investigators. In: The New England Journal of Medicine, DOI 10.1056/NEJMoa2105911. Published August 04, 2021. Available at: https://doi.org/10.1056/NEJMoa2105911."/>
<document>
<url value="https://fevir.net/resources/Citation/7636"/>
</document>
<resourceReference>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="7636"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
</resourceReference>
</relatesTo>
<publicationForm>
<publishedIn>
<type>
<coding>
<system value="http://hl7.org/fhir/published-in-type"/>
<code value="D019991"/>
<display value="Database"/>
</coding>
</type>
<title
value="Fast Evidence Interoperability Resources (FEvIR) Platform"/>
<publisher>
<display value="Computable Publishing LLC"/>
</publisher>
<publisherLocation value="Ipswich, MA, USA"/>
</publishedIn>
<articleDate value="2021-08-05"/>
<lastRevisionDate value="2021-08-25"/>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
</publicationForm>
<webLocation>
<classifier>
<coding>
<system value="http://hl7.org/fhir/artifact-url-classifier"/>
<code value="computable-resource"/>
<display value="Computable resource"/>
</coding>
</classifier>
<classifier>
<coding>
<system value="http://hl7.org/fhir/artifact-url-classifier"/>
<code value="json"/>
<display value="JSON"/>
</coding>
</classifier>
<url value="https://fevir.net/resources/Evidence/7637"/>
</webLocation>
<classification>
<type>
<coding>
<system
value="http://hl7.org/fhir/cited-artifact-classification-type"/>
<code value="knowledge-artifact-type"/>
<display value="Knowledge Artifact Type"/>
</coding>
</type>
<classifier>
<coding>
<system value="http://hl7.org/fhir/citation-artifact-classifier"/>
<code value="fhir-resource"/>
<display value="FHIR Resource"/>
</coding>
<text value="FHIR Resource"/>
</classifier>
</classification>
<classification>
<type>
<coding>
<system value="http://hl7.org/fhir/citation-artifact-classifier"/>
<code value="fhir-resource"/>
<display value="FHIR Resource"/>
</coding>
<text value="fhir-resource"/>
</type>
<classifier>
<coding>
<system value="http://hl7.org/fhir/fhir-types"/>
<code value="Evidence"/>
<display value="Evidence"/>
</coding>
<text value="Evidence"/>
</classifier>
</classification>
<contributorship>
<complete value="true"/>
<entry>
<contributor>
<reference value="#contributor0"/>
<type value="Practitioner"/>
</contributor>
<forenameInitials value="BS"/>
<affiliation>
<display value="Computable Publishing LLC"/>
</affiliation>
<affiliation>
<display value="Scientific Knowledge Accelerator Foundation"/>
</affiliation>
<affiliation>
<display value="COVID-19 Knowledge Accelerator"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="conceptualization"/>
<display value="Conceptualization"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="data-curation"/>
<display value="Data curation"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="investigation"/>
<display value="Investigation"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="methodology"/>
<display value="Methodology"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="software"/>
<display value="Software"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-original-draft"/>
<display value="Writing - original draft"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
<contributionInstance>
<type>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="Risk of bias assessment"/>
</type>
<time value="2021-08-05"/>
</contributionInstance>
<correspondingContact value="true"/>
</entry>
<entry>
<contributor>
<reference value="#contributor1"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display value="Hassanah Consulting"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-review-editing"/>
<display value="Writing - review & editing"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="formal-analysis"/>
<display value="Formal analysis"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="investigation"/>
<display value="Investigation"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="validation"/>
<display value="Validation"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="reviewer"/>
<display value="Reviewer"/>
</coding>
</role>
<contributionInstance>
<type>
<coding>
<system
value="http://hl7.org/fhir/artifact-contribution-instance-type"/>
<code value="reviewed"/>
<display value="Reviewed"/>
</coding>
</type>
<time value="2021-08-05"/>
</contributionInstance>
<contributionInstance>
<type>
<coding>
<system
value="http://hl7.org/fhir/artifact-contribution-instance-type"/>
<code value="reviewed"/>
<display value="Reviewed"/>
</coding>
</type>
<time value="2021-08-06"/>
</contributionInstance>
</entry>
<entry>
<contributor>
<reference value="#contributor2"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display value="Johns Hopkins University"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="investigation"/>
<display value="Investigation"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="methodology"/>
<display value="Methodology"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-original-draft"/>
<display value="Writing - original draft"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
</entry>
<entry>
<contributor>
<reference value="#contributor3"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display value="Cochrane Iran Associate Centre"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="investigation"/>
<display value="Investigation"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="methodology"/>
<display value="Methodology"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="validation"/>
<display value="Validation"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-review-editing"/>
<display value="Writing - review & editing"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
</entry>
<entry>
<contributor>
<reference value="#contributor4"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display value="Computable Publishing LLC"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="project-administration"/>
<display value="Project administration"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="investigation"/>
<display value="Investigation"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-review-editing"/>
<display value="Writing - review & editing"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
</entry>
<entry>
<contributor>
<reference value="#contributor5"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display value="University of Arizona"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="formal-analysis"/>
<display value="Formal analysis"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="investigation"/>
<display value="Investigation"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-review-editing"/>
<display value="Writing - review & editing"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="reviewer"/>
<display value="Reviewer"/>
</coding>
</role>
<contributionInstance>
<type>
<coding>
<system
value="http://hl7.org/fhir/artifact-contribution-instance-type"/>
<code value="reviewed"/>
<display value="Reviewed"/>
</coding>
</type>
<time value="2021-08-07"/>
</contributionInstance>
</entry>
<entry>
<contributor>
<reference value="#contributor6"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display value="Duodecim Medical Publications Ltd., Finland"/>
</affiliation>
<affiliation>
<display value="Scientific Knowledge Accelerator Foundation"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-review-editing"/>
<display value="Writing - review & editing"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
<contributionInstance>
<type>
<coding>
<system
value="http://hl7.org/fhir/artifact-contribution-instance-type"/>
<code value="reviewed"/>
<display value="Reviewed"/>
</coding>
</type>
<time value="2021-08-09"/>
</contributionInstance>
</entry>
<entry>
<contributor>
<reference value="#contributor7"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display value="Value Momentum"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="methodology"/>
<display value="Methodology"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="validation"/>
<display value="Validation"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="reviewer"/>
<display value="Reviewer"/>
</coding>
</role>
</entry>
<entry>
<contributor>
<reference value="#contributor8"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display value="McMaster University"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="formal-analysis"/>
<display value="Formal analysis"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-review-editing"/>
<display value="Writing - review & editing"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="reviewer"/>
<display value="Reviewer"/>
</coding>
</role>
</entry>
<entry>
<contributor>
<reference value="#contributor9"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display value="Sejong University, Seoul, South Korea"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="formal-analysis"/>
<display value="Formal analysis"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-review-editing"/>
<display value="Writing - review & editing"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="reviewer"/>
<display value="Reviewer"/>
</coding>
</role>
</entry>
<entry>
<contributor>
<reference value="#contributor10"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display
value="National Institute of Diabetes & Digestive & Kidney Diseases"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="formal-analysis"/>
<display value="Formal analysis"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-review-editing"/>
<display value="Writing - review & editing"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="reviewer"/>
<display value="Reviewer"/>
</coding>
</role>
</entry>
<entry>
<contributor>
<reference value="#contributor11"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display value="Mayo Clinic Arizona"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-review-editing"/>
<display value="Writing - review & editing"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="Clinical commentary"/>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="reviewer"/>
<display value="Reviewer"/>
</coding>
</role>
</entry>
<entry>
<contributor>
<reference value="#contributor12"/>
<type value="Practitioner"/>
</contributor>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="writing-review-editing"/>
<display value="Writing - review & editing"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="reviewer"/>
<display value="Reviewer"/>
</coding>
</role>
</entry>
</contributorship>
</citedArtifact>
</Citation>
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2023-12-17
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change